Xanthomicrol Exerts Antiangiogenic and Antitumor Effects in a Mouse Melanoma (B16F10) Allograft Model

Figure 2

Xanthomicrol decreased viability of B16F10 melanoma cells. HFFF-P16 treated with vehicle (0.2% DMSO) and xanthomicrol (a). Serum-starved B16F10 cells were treated with vehicle (0.2% DMSO), xanthomicrol (b), or thalidomide (c) for 48 h, and cell viability was determined by the MTT assay. Data are represented as mean ± SEM (^∗∗, ^∗∗∗ vs. vehicle group).

(a)

(b)

(c)